FindTrial
Sign In

A clinical trial to study the effect of dexmedetomidine and dexamethasone with ropivacaine to reduce pain in upper limb bone surgeries

COMPARISION OF DEXMEDETOMIDINE VS DEXAMETHASONE AS AN ADJUVANT FOR 0.5%ROPIVACAINE IN ULTRASOUND GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK IN UPPER LIMB ORTHOPAEDICS SURGERIES - PRCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047105
Enrollment
60
Registered
2022-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: GROUP B - DEXAMETHASONE WITH 0.5% ROPIVACAINE: DEXAMETHASONE 8 MILLIGRAM, SINGLE DOSE, LOCAL INFILTRATION AROUND BRACHIAL PLEXUS Intervention2: GROUP-A DEXMEDITOMIDINE WITH 0.5% ROPIVAC

Sponsors

SRI SIDDHARTHA MEDICAL COLLEGE AND HOSPITAL,TUMKUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients of ASA physical status grade1 and grade2 •Undergoing upper limb surgery under supraclavicular block.

Exclusion criteria

Exclusion criteria: •Infection at injection site. •Pre-existing peripheral neuropathy. •History of allergy to any of the study drugs. •Peripheral vascular disease. •Suspected coagulopathy. •Respiratory illness. •Uncooperative patients. •Unwillingness to give consent. •Patient with history of seizures

Design outcomes

Primary

MeasureTime frame
the onset and duration of motor blockadeTimepoint: 5 10 15 20 minutes after injection—

Secondary

MeasureTime frame
the duration of sensory and motor blockadeTimepoint: 0 4 8 12 hours respectively after injection—

Countries

India

Contacts

Public ContactDRSUJAY JN

SRI SIDDHARTHA MEDICAL COLLEGE AND HOSPITAL,TUMKUR

drsujayjn79@yahoo.com8310859945

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026